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Introduction
Congenital cystic adenomatoid malformations (CCAMs)
are benign hamartomatous or dysplastic lung tumors
characterized by an overgrowth of terminal bronchioles.
CCAMs have been classified histologically into three
types, mainly based on cyst size as reported by Rosado-
de-Christenson and Stocker [1]. Adzick et al [2] differ-
entiated CCAMs diagnosed antenatally with ultrasound
into macrocytic and microcystic lesions. The majority of
cystic adenomatoid malformations of the lung decreased
in size in utero. An acknowledged poor prognosis has been
associated with the presence of hydrops. Polyhydramnios
is another sign suggesting a poor outlook and is con-
sidered by some practitioners to be an indication for
shunt insertion [3]. The reported perinatal mortality
rate of cases with antenatally diagnosed CCAMs has
varied greatly, ranging from 9% to as high as 49%. The
discrepancies may be because some mothers terminated
their pregnancies as a result of antenatal predictors of
poor prognoses, such as hydrops or significant medi-
astinal shift [4]. However, the outcomes of prenatally
recognized CCAMs have been better in recent reports
than in the past.
Here, we present three cases of prenatally diagnosed
CCAM. We used the VOCAL (Virtual Organ Computer-
aided Analysis) modality for three-dimensional (3-D)
sonographic volume measurement to determine the
CCAM volume.
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SUMMARY
Objective: The aim of this study was to describe the natural history and outcomes of fetal congenital cystic 
adenomatoid malformation (CCAM) of the lung in three antenatally diagnosed cases.
Case Report: Three women whose fetuses had CCAM of the lung between 2004 and 2006 chose to continue
their pregnancies. We followed up these fetuses every 2 weeks and observed whether there were CCAM-related
complications, such as polyhydramnios, mediastinal shifting, and even hydrops fetalis. We also used three-
dimensional ultrasound using the VOCAL (Virtual Organ Computer-aided Analysis) rotational technique to cal-
culate CCAM volume serially until delivery. At presentation, the three cases of fetal CCAM were all unilateral
and microcystic. Two were complicated by mediastinal shift, but none had hydrops fetalis. Serial ultrasound
volumetry demonstrated a trend toward a decreasing CCAM volume, despite an initial increase in volume.
Complete resolution was noted in two cases by antenatal sonography. However, persistent lung lesions were
found in two cases by postnatal chest radiography and in all cases by postnatal computed tomography scans.
Conclusion: The outcomes of the prenatally detected CCAMs were good in our cases. If the CCAM is not com-
plicated by hydrops fetalis, maintaining the pregnancy with continuing management seems to be a reasonable
recommendation. Despite antenatal resolution of CCAM on ultrasound, postnatal examination with chest
radiography and computed tomography scan is necessary. [Taiwan J Obstet Gynecol 2009;48(3):278–281]
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Case Report
From 2004 to 2006, we collected information on three
fetuses with CCAM diagnosed prenatally. Cases 2 and
3 were referred to our obstetric outpatient department
at 22 and 18 weeks’ gestation, because congenital fetal
anomaly was suggested by the local health care provider.
The woman in Case 1 had regular prenatal examina-
tions at our obstetric outpatient department from the
first trimester, and CCAM type II was suggested at 19
weeks’ gestation. All women chose to continue their preg-
nancies after counseling. We followed up these preg-
nancies with 3-D ultrasound every 2 weeks until delivery.
A commercially available GE Voluson 730 Expert ultra-
sound system scanner (GE Medical Systems, Milwaukee,
WI, USA) equipped with a multifrequency transabdom-
inal volumetric probe (3–9 MHz) was used. The char-
acteristics of the three cases are presented in Table 1.
We also analyzed the postnatal outcomes of these three
babies.
Ultrasonography showed CCAM type II in Cases 1
and 3, and CCAM mixed type II and III in Case 2. The
perinatal outcomes are listed in Table 2. There were no
hydrops fetalis or other fetal anomalies noted in the
three cases. Therefore, all three mothers decided to con-
tinue their pregnancies. Two fetuses had a mediastinal
shift at the initial presentation, which improved after
the CCAM volume decreased with advancing gestational
age. Peak CCAM volume occurred at 22–27 weeks’
gestation. In all three cases, CCAM volume decreased
with advancing gestational age, despite the slight ini-
tial increase (Figure). Prenatal ultrasonography showed
complete resolution in Cases 1 and 2, in which post-
natal imaging with both chest X-ray and computed
tomography (CT) scan demonstrated persistent lesions.
Although there was a small CCAM lesion before birth
in Case 3, the postnatal chest X-ray revealed no evi-
dence of airspace consolidation. However, the CT scan
showed multiple cystic lesions with areas of solid tis-
sue in the right lower lobe.
The infant in Case 1 was admitted because of atypical
pneumonia at 1 year of age. At that admission, she
underwent surgery with lobectomy, and the histologic
report showed extralobar sequestration and CCAM.
Table 1. Characteristics of the fetal congenital cystic adenomatoid malformations (CCAMs) in our study
Case 1 Case 2 Case 3
Fetal sex Female Male Female
GA at diagnosis (wk) 19 22 18
Type of CCAM by Stocker’s criteria Type 2 Mixed type 2 and type 3 Type 2
GA at peak volume (wk) 22 24 27
Complete resolution as determined Yes, at 35 weeks Yes, at 36 weeks No
by ultrasonography
Site of lesion Right Left Right
Mediastinal shifting N Y Y
Polyhydramnios N N N
Ascites N N N
Hydrops fetalis N N N
GA = gestational age; N = negative finding; Y = positive finding.
Table 2. Perinatal outcomes of the cystic adenomatoid malformations (CCAMs) in our study
Case 1 Case 2 Case 3
Site of lesion as determined Right lower lobe Left upper lobe Right lower lobe
by postnatal CT scan
Delivery age (wk) 38 40 34†
Type of delivery Cesarean section* Vaginal delivery Vaginal delivery
Postnatal outcome Status post lobectomy Bilateral pneumothorax  Normal growth; one 
at 1 year old; alive at neonatal stage; status pneumonia attack at
postlobectomy at  2 years old; alive
6 months of  age; alive
Histologic diagnosis Extralobar sequestration CCAM, type 2 Surgery not performed
and CCAM
*Indication for cesarean section was previous cesarean section; †preterm labor with full cervical dilatation at admission. CT = computed tomography.
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After the operation, she had a smooth recovery and
was discharged. At the time of writing, she had had
one more admission for bronchopneumonia. The infant
in Case 2 had bilateral pneumothorax during the neona-
tal stage. He underwent a lobectomy at 6 months of
age, and the histologic diagnosis was CCAM type II.
Both infants had a good recovery and progressed well.
The infant in Case 3 had no emergency perinatal inter-
vention and no respiratory distress at birth. She had
normal growth and never had pneumonia. At the time of
writing, surgical intervention had not yet been arranged.
Discussion
CCAM is usually restricted to a single lobe and occurs
in isolation. The CCAMs in all our cases were located in
a single lobe. Associated anomalies are rare, according
to published reports [5,6], which is compatible with
the results of our study. Males and females are equally
affected. Invasive testing is not indicated if a precise
diagnosis can be made using ultrasonography. Ultraso-
nographic examinations at least every 2 weeks seem to
be appropriate for detecting early evidence of hydrops
or polyhydramnios [3].
Prognostic factors associated with CCAM of the
lung have always been an issue. The most common
advanced prenatal ultrasonographic findings sugges-
tive of poor prognosis included polyhydramnios, medi-
astinal shifting, ascites, microcystic lesion (CCAM type
III), hydrops fetalis, and bilateral lung involvement [5,7].
De Santis et al [8] and Teodoro et al [9] affirmed that
only hydrops fetalis has negative prognostic significance.
Adzick and Harrison [10] also reported that fetuses
with CCAM, but without hydrops, have good chances
of survival with maternal transport, planned delivery,
and immediate neonatal resuscitation and surgery. In
accordance with the reports of Ierullo et al [4] and
Illanes et al [6], the presence of a mediastinal shift is
not a marker of a poor prognosis. Two of our cases with
CCAM had mediastinal shifting. The infants had nor-
mal growth and were healthy at the time of writing.
Furthermore, in the study by Ierullo et al [4], approxi-
mately 50% of fetuses with hydrops did survive with
continued management. None of our three cases had
hydrops, so continuing the pregnancies was suggested.
Their outcomes had been good at the time of this report.
Most of the researchers used the cystic adenoma-
toid malformation volume ratio (CVR), which is defined
as the estimated volume of the CCAM divided by the
head circumference, as an index to predict the devel-
opment of hydrops and the perinatal survival rate.
When the CVR was greater than 1.6, the prognosis was
poorer [11–13]. Increased fetal head circumference
accompanies fetal growth, so decreased CVR may not
represent the regression of CCAM volume. We adopted
the VOCAL technique, a new modality for 3-D sono-
graphic volume measurement, to calculate CCAM vol-
ume in this study. Peak CCAM size occurred at 22–27
weeks’ gestation, and then decreased with advanced
gestational age.
Some researchers observed that asymptomatic babies
may have normal postnatal chest radiographs, but
persistent lesions on CT scans [7,14,15]. Calvert and
Lakhoo [16] even recommended CT scans as the first
line of postnatal investigation for asymptomatic babies
diagnosed antenatally with suggested CCAM. In our
study, complete prenatal resolution was found in Cases
1 and 2, but their postnatal imaging with both chest
X-rays and CT scans presented persistent lesions.
Although there was a persistent small CCAM lesion in
Case 3 prenatally, postnatal chest X-ray revealed no
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Figure. Records of cystic adenomatoid malformation (CCAM) volume by serial prenatal three-dimensional ultrasonography.
Peak CCAM volume occurred at 22–27 weeks; CCAM volume decreased with advancing gestational age, despite a slight
increase initially.
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evidence of airspace consolidation. However, CT scans
showed multiple cystic lesions with areas of solid tis-
sue in the right lower lobe. Prenatal magnetic resonance
imaging was not arranged in our cases, because the
cost was high and it would not change our obstetric
diagnosis.
There have been few reports regarding recommen-
dations for timing of surgery in asymptomatic CCAM.
Most researchers agree that elective surgery should be
performed because of the long-term risks, particularly
of infection, pneumothorax and, more rarely, malig-
nancy [7,16]. Calvert and Lakhoo [16] found that 13
of 19 cases with antenatally diagnosed CCAM were
asymptomatic. They suggested that surgery should be
arranged at around 3–6 months of age in asympto-
matic cases with significant lesions present on the post-
natal CT scan; 50% of the asymptomatic cases which
underwent surgery at more than 6 months of age had
infections [16]. However, in our study, Cases 1 and 3
were asymptomatic, and elective surgery at 1 year of
age, at least, was suggested by the pediatric surgeon.
The procedure itself was well tolerated by the infants, 
and compensatory lung growth occurred with normal
respiratory function.
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